Text and Data Mining valid from 2019-12-12
First Online: 12 December 2019
Compliance with Ethical Standards
: MGP is a co-inventor on a US patent covering 18F-DCFPyL and as such is entitled to a portion of any licensing fees and royalties generated by this technology. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict-of-interest policies. SPR is a consultant to Progenics Pharmaceuticals, the licensee of 18F-DCFPyL. MAG has served as a consultant to Progenics Pharmaceuticals. SPR, MAG, KJP, and MGP receive research funding from Progenics Pharmaceuticals. No other potential conflicts of interest relevant to this article exist.